Tesamorelin

**Tesamorelin (Growth Hormone-Releasing Hormone Analog)** Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), comprised of the first 44 amino acids of human GHRH with a hexenoyl group attached to the N-terminal tyrosine residue. This structural modification enhances its metabolic stability and resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-IV) compared to the endogenous peptide. In laboratory research environments, Tesamorelin is utilized to investigate the stimulation of endogenous growth hormone (GH) secretion. It functions as a potent agonist at the GHRH receptors located on the somatotrophs of the anterior pituitary gland. The binding of Tesamorelin triggers a signal transduction pathway involving the activation of adenylate cyclase, resulting in increased intracellular cyclic adenosine monophosphate (cAMP) and the subsequent pulsatile release of GH. Preclinical research into Tesamorelin focuses heavily on its influence over lipid metabolism and body composition in various animal models. Unlike exogenous growth hormone administration, which can bypass regulatory feedback loops, Tesamorelin-induced GH release maintains the physiological negative feedback mechanism via somatostatin, making it a distinct tool for studying regulated somatotropic signaling. Investigators utilize this compound to explore the downstream effects of elevated GH and Insulin-like Growth Factor 1 (IGF-1), particularly concerning the modulation of ectopic adipose tissue, glucose homeostasis, and the preservation of lean muscle mass. Furthermore, current in-vitro studies examine its potential neuroprotective properties and its role in modulating cognitive biomarkers in models of age-related decline. For laboratory applications, Tesamorelin is typically supplied as a lyophilized white powder to ensure long-term stability. It should be stored at -20°C for extended periods; however, it remains stable at refrigerated temperatures (2-8°C) for short-term use. Upon reconstitution with an appropriate bacteriostatic or sterile diluent, the peptide should be gently swirled rather than shaken to prevent denaturation of the delicate amino acid chain. Once in solution, the product is susceptible to degradation and should be stored at 2-8°C and utilized within a specified timeframe according to experimental protocols. **This product is intended for IN-VITRO RESEARCH AND LABORATORY USE ONLY. It is not for human or veterinary diagnostic or therapeutic use.**